Christine J. Guico-Pabia

Insider Reports History

Entity
Individual
Location
C/O Nabriva Therapeutics Plc, 414 Commerce Drive, Suite 120, Fort Washington, PA
Signature
/s/ J. Christopher Naftzger, power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christine J. Guico-Pabia:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nabriva Therapeutics plc Chief Medical Officer Stock Appreciation Right 71.5K Aug 11, 2022 Direct
Nabriva Therapeutics plc Chief Medical Officer Phantom Shares 35.7K Aug 11, 2022 Direct
Nabriva Therapeutics plc Chief Medical Officer Restricted Stock Units 0 Aug 11, 2022 Direct
Nabriva Therapeutics plc Chief Medical Officer Share Options 0 Aug 11, 2022 Direct

Insider Reports Filed by Christine J. Guico-Pabia

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NBRV Nabriva Therapeutics plc Aug 11, 2022 4 $0 4 Aug 15, 2022 Chief Medical Officer
NBRV Nabriva Therapeutics plc Jan 28, 2022 2 $0 4 Feb 1, 2022 Chief Medical Officer
NBRV Nabriva Therapeutics plc Oct 29, 2021 1 $0 4 Nov 1, 2021 Chief Medical Officer
NBRV Nabriva Therapeutics plc Oct 1, 2021 0 $0 3 Oct 7, 2021 Chief Medical Officer